InsidersTradesSigma
경남제약 Stock: price and insider trades · South Korea · DART (FSS)
Track the 경남제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 경남제약 has logged 56 public disclosures. Market capitalisation: €27.3bn. The latest transaction was reported on 8 July 2026 (Other). Among the most active insiders: 빌리언스. The full history is accessible without an account.
56
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
20 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,292 of 25,921 companies
17.6
score / 100
Value12
Quality24
FCF yld-11%
Earn yld-33%
EV/EBITDA·
ROE·
Gross mgn27%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 July 2026
Declarations56 total
ShareKRXDART:20240524000550
ShareKRXDART:20240517000368
25 of 56 declarations
About 경남제약
경남제약 is a South Korean company specializing in the healthcare and pharmaceutical sector. It is listed on the XKRX.